Fund shareholders of ALNYLAM PHARMACEUTICALS INC
ISIN US02043Q1076 · United States · LEI 529900S3ZI14OWRJII50
- Fund shareholders
- 737
- Of which ETFs
- 212 525 other funds
- Value held
- ≈ 21.6B $ 21.5B $ · 1.4B SEK · 14.6M €
- Share of capital
- 56.4 % of 133.8M shares on Jul 24, 2026
737 funds hold this company. This table lists the 733 that declare it in a regulatory filing. The other 4 publish their holdings in their own reports. The “Fund reports” tab lists them, with their weight.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 112,976 | 23.2M $ | 0.02 % | 0.08 % | as of Jul 31, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 112,392 | 23.1M $ | 0.04 % | 0.08 % | as of Jul 31, 2026 ↗ |
| Fidelity Series Stock Selector Large Cap Value Fund Fidelity Devonshire Trust | 111,200 | 22.9M $ | 0.13 % | 0.08 % | as of Jul 31, 2026 ↗ |
| VANGUARD MID-CAP GROWTH FUND VANGUARD WHITEHALL FUNDS | 110,193 | 22.6M $ | 0.84 % | 0.08 % | as of Jul 31, 2026 ↗ |
| Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust | 107,407 | 32.3M $ | 0.29 % | 0.08 % | as of Jun 30, 2026 ↗ |
| MassMutual Mid Cap Growth Fund MASSMUTUAL SELECT FUNDS | 106,075 | 31.9M $ | 1.28 % | 0.08 % | as of Jun 30, 2026 ↗ |
| Fidelity U.S. Equity Central Fund Fidelity Central Investment Portfolios LLC | 106,000 | 31.9M $ | 0.13 % | 0.08 % | as of Jun 30, 2026 ↗ |
| Empower T. Rowe Price Mid Cap Growth Fund EMPOWER FUNDS, INC. | 105,590 | 31.8M $ | 1.55 % | 0.08 % | as of Jun 30, 2026 ↗ |
| Fidelity Blue Chip Growth K6 Fund Fidelity Securities Fund | 103,856 | 21.3M $ | 0.10 % | 0.08 % | as of Jul 31, 2026 ↗ |
| JPMorgan Active Growth ETF J.P. Morgan Exchange-Traded Fund Trust | 100,030 | 30.1M $ | 0.30 % | 0.07 % | as of Jun 30, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 94,913 | 28.7M $ | 0.49 % | 0.07 % | as of May 29, 2026 ↗ |
| Fidelity Growth Discovery Fund Fidelity Hastings Street Trust | 93,819 | 28.2M $ | 0.42 % | 0.07 % | as of Jun 30, 2026 ↗ |
| iShares Russell 1000 ETF iShares Trust | 92,716 | 27.9M $ | 0.06 % | 0.07 % | as of Jun 30, 2026 ↗ |
| Fidelity Enhanced Large Cap Growth ETF Fidelity Covington Trust | 88,675 | 26.7M $ | 0.47 % | 0.07 % | as of Jun 30, 2026 ↗ |
| Goldman Sachs ActiveBeta(R) U.S. Large Cap Equity ETF Goldman Sachs ETF Trust | 88,082 | 26.6M $ | 0.17 % | 0.07 % | as of May 31, 2026 ↗ |
| JPMorgan Mid Cap Equity Fund JPMorgan Trust I | 86,432 | 26M $ | 0.42 % | 0.06 % | as of Jun 30, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 80,893 | 16.6M $ | 0.04 % | 0.06 % | as of Jul 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 80,470 | 24.3M $ | 0.09 % | 0.06 % | as of May 31, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 78,259 | 23.6M $ | 0.05 % | 0.06 % | as of May 31, 2026 ↗ |
| iShares U.S. Healthcare ETF iShares Trust | 78,219 | 16.1M $ | 0.45 % | 0.06 % | as of Jul 31, 2026 ↗ |
| Large Cap Index Master Portfolio Master Investment Portfolio | 77,689 | 23.4M $ | 0.06 % | 0.06 % | as of Jun 30, 2026 ↗ |
| Capital World Growth & Income Fund Capital World Growth & Income Fund | 75,608 | 22.8M $ | 0.01 % | 0.06 % | as of May 31, 2026 ↗ |
| NEOS Nasdaq-100(R) High Income ETF NEOS ETF Trust | 75,487 | 22.7M $ | 0.17 % | 0.06 % | as of Jun 30, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 75,400 | 22.7M $ | 1.96 % | 0.06 % | as of Jun 30, 2026 ↗ |
| Nuveen Large Cap Growth Index Fund TIAA-CREF Funds | 74,884 | 15.4M $ | 0.08 % | 0.06 % | as of Jul 31, 2026 ↗ |
| Optimum Large Cap Growth Fund Optimum Fund Trust | 73,248 | 22M $ | 1.14 % | 0.05 % | as of Jun 30, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 72,629 | 14.9M $ | 0.04 % | 0.05 % | as of Jul 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 71,958 | 21.7M $ | 0.03 % | 0.05 % | as of Jun 30, 2026 ↗ |
| iShares Morningstar Mid-Cap Growth ETF iShares Trust | 71,271 | 14.6M $ | 0.37 % | 0.05 % | as of Jul 31, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 70,564 | 14.5M $ | 0.03 % | 0.05 % | as of Jul 31, 2026 ↗ |
| ProShares UltraPro QQQ ProShares Trust | 70,211 | 21.2M $ | 0.05 % | 0.05 % | as of May 31, 2026 ↗ |
| Handelsbanken Hälsovård Tema Handelsbanken Fonder AB | 69,000 | 217.5M SEK | 0.98 % | 0.05 % | as of Mar 31, 2026 ↗ |
| EQ/Loomis Sayles Growth Portfolio EQ Advisors Trust | 68,397 | 20.6M $ | 2.56 % | 0.05 % | as of Jun 30, 2026 ↗ |
| Neuberger Mid Cap Growth Fund NEUBERGER BERMAN EQUITY FUNDS | 67,557 | 20.4M $ | 0.90 % | 0.05 % | as of May 31, 2026 ↗ |
| Federated Hermes Kaufmann Fund Federated Hermes Equity Funds | 66,300 | 13.6M $ | 0.28 % | 0.05 % | as of Jul 31, 2026 ↗ |
| VANGUARD FTSE SOCIAL INDEX FUND VANGUARD WORLD FUND | 65,755 | 19.9M $ | 0.07 % | 0.05 % | as of May 31, 2026 ↗ |
| Fidelity Series Blue Chip Growth Fund Fidelity Securities Fund | 65,481 | 13.5M $ | 0.08 % | 0.05 % | as of Jul 31, 2026 ↗ |
| Fidelity Contrafund K6 Fidelity Contrafund | 65,062 | 19.6M $ | 0.05 % | 0.05 % | as of Jun 30, 2026 ↗ |
| VANGUARD GLOBAL EQUITY FUND VANGUARD HORIZON FUNDS | 64,391 | 19.4M $ | 0.26 % | 0.05 % | as of Jun 30, 2026 ↗ |
| JNL/Mellon Nasdaq 100 Index Fund JNL Series Trust | 64,362 | 19.4M $ | 0.17 % | 0.05 % | as of Jun 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 63,818 | 19.2M $ | 0.06 % | 0.05 % | as of Jun 30, 2026 ↗ |
| Fidelity MSCI Health Care Index ETF FIDELITY COVINGTON TRUST | 63,090 | 13M $ | 0.39 % | 0.05 % | as of Jul 31, 2026 ↗ |
| Six Circles Managed Equity Portfolio U.S. Unconstrained Fund SIX CIRCLES TRUST | 58,956 | 17.7M $ | 0.05 % | 0.04 % | as of Jun 30, 2026 ↗ |
| Multi-Manager Large Cap Growth Strategies Fund COLUMBIA FUNDS SERIES TRUST I | 57,928 | 17.4M $ | 0.39 % | 0.04 % | as of Jun 30, 2026 ↗ |
| Bridge Builder Large Cap Value Fund Bridge Builder Trust | 57,467 | 17.3M $ | 0.06 % | 0.04 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Mid Cap Growth Portfolio Brighthouse Funds Trust I | 56,621 | 17M $ | 1.52 % | 0.04 % | as of Jun 30, 2026 ↗ |
| Nationwide Large Cap Equity Portfolio Nationwide Mutual Funds | 55,730 | 11.5M $ | 0.45 % | 0.04 % | as of Jul 31, 2026 ↗ |
| VANGUARD TAX-MANAGED CAPITAL APPRECIATION FUND VANGUARD TAX-MANAGED FUNDS | 55,289 | 16.6M $ | 0.06 % | 0.04 % | as of Jun 30, 2026 ↗ |
| JNL/Mellon Healthcare Sector Fund JNL Series Trust | 54,660 | 16.5M $ | 0.61 % | 0.04 % | as of Jun 30, 2026 ↗ |
| Victory Nasdaq-100 Index Fund Victory Portfolios III | 54,370 | 11.2M $ | 0.12 % | 0.04 % | as of Jul 31, 2026 ↗ |
| LVIP T. Rowe Price Structured Mid-Cap Growth Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 54,000 | 16.3M $ | 1.10 % | 0.04 % | as of Jun 30, 2026 ↗ |
| Dodge & Cox Balanced Fund Dodge & Cox Funds | 53,400 | 16.1M $ | 0.11 % | 0.04 % | as of Jun 30, 2026 ↗ |
| ProShares Ultra QQQ ProShares Trust | 52,508 | 15.9M $ | 0.11 % | 0.04 % | as of May 31, 2026 ↗ |
| EQ/Large Cap Growth Managed Volatility Portfolio EQ Advisors Trust | 52,210 | 15.7M $ | 0.35 % | 0.04 % | as of Jun 30, 2026 ↗ |
| Mid Cap Growth Stock Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 51,400 | 15.5M $ | 1.39 % | 0.04 % | as of Jun 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 51,286 | 10.5M $ | 0.91 % | 0.04 % | as of Jul 31, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 50,880 | 15.4M $ | 0.02 % | 0.04 % | as of May 31, 2026 ↗ |
| Fidelity Large Cap Stock Fund Fidelity Concord Street Trust | 50,648 | 10.4M $ | 0.10 % | 0.04 % | as of Jul 31, 2026 ↗ |
| Global X NASDAQ 100 Covered Call ETF GLOBAL X FUNDS | 50,622 | 10.4M $ | 0.13 % | 0.04 % | as of Jul 31, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 50,358 | 15.2M $ | 3.83 % | 0.04 % | as of Jun 30, 2026 ↗ |
| Global Growth Fund AMERICAN FUNDS INSURANCE SERIES | 50,179 | 15.1M $ | 0.14 % | 0.04 % | as of Jun 30, 2026 ↗ |
| Franklin U.S. Mid Cap Multifactor Index ETF Franklin Templeton ETF Trust | 49,820 | 15M $ | 0.98 % | 0.04 % | as of Jun 30, 2026 ↗ |
| LargeCap Growth Fund I Principal Funds, Inc | 48,788 | 10M $ | 0.18 % | 0.04 % | as of Jul 31, 2026 ↗ |
| Fidelity Fund Fidelity Hastings Street Trust | 48,700 | 14.7M $ | 0.16 % | 0.04 % | as of Jun 30, 2026 ↗ |
| Six Circles U.S. Unconstrained Equity Fund SIX CIRCLES TRUST | 48,643 | 14.6M $ | 0.04 % | 0.04 % | as of Jun 30, 2026 ↗ |
| Fidelity New Millennium Fund Fidelity Mt. Vernon Street Trust | 48,400 | 14.6M $ | 0.25 % | 0.04 % | as of May 31, 2026 ↗ |
| Fidelity Blue Chip Growth ETF Fidelity Covington Trust | 47,533 | 9.8M $ | 0.14 % | 0.04 % | as of Jul 31, 2026 ↗ |
| iShares ESG Aware MSCI USA ETF iShares Trust | 47,319 | 14.3M $ | 0.08 % | 0.04 % | as of May 31, 2026 ↗ |
| STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOLIO STATE STREET INSTITUTIONAL INVESTMENT TRUST | 46,480 | 14M $ | 0.45 % | 0.03 % | as of Jun 30, 2026 ↗ |
| MID-CAP INDEX PORTFOLIO VANGUARD VARIABLE INSURANCE FUNDS | 45,604 | 13.7M $ | 0.39 % | 0.03 % | as of Jun 30, 2026 ↗ |
| VANGUARD GROWTH AND INCOME FUND VANGUARD QUANTITATIVE FUNDS | 45,560 | 13.7M $ | 0.07 % | 0.03 % | as of Jun 30, 2026 ↗ |
| Mid-Cap Growth Portfolio PACIFIC SELECT FUND | 45,085 | 13.6M $ | 2.00 % | 0.03 % | as of Jun 30, 2026 ↗ |
| Direxion NASDAQ-100 Equal Weighted Index Shares Direxion Shares ETF Trust | 45,011 | 9.3M $ | 0.69 % | 0.03 % | as of Jul 31, 2026 ↗ |
| VOYA MIDCAP OPPORTUNITIES PORTFOLIO Voya Variable Products Trust | 44,737 | 13.5M $ | 1.33 % | 0.03 % | as of Jun 30, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 43,457 | 8.9M $ | 3.17 % | 0.03 % | as of Jul 31, 2026 ↗ |
| Capital Appreciation Value Fund John Hancock Funds II | 43,310 | 13.1M $ | 0.92 % | 0.03 % | as of May 31, 2026 ↗ |
| Schwab 1000 Index Fund SCHWAB INVESTMENTS | 42,385 | 8.7M $ | 0.04 % | 0.03 % | as of Jul 31, 2026 ↗ |
| iShares MSCI ACWI ETF iShares Trust | 42,198 | 8.7M $ | 0.03 % | 0.03 % | as of Jul 31, 2026 ↗ |
| Natixis U.S. Equity Opportunities Fund Natixis Funds Trust I | 41,650 | 12.5M $ | 1.08 % | 0.03 % | as of Jun 30, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund Janus Investment Fund | 41,334 | 12.4M $ | 0.21 % | 0.03 % | as of Jun 30, 2026 ↗ |
| Dimensional U.S. Equity Market ETF Dimensional ETF Trust | 40,351 | 8.3M $ | 0.04 % | 0.03 % | as of Jul 31, 2026 ↗ |
| CIBC ATLAS MID CAP EQUITY FUND ADVISORS' INNER CIRCLE FUND | 39,832 | 8.2M $ | 1.22 % | 0.03 % | as of Jul 31, 2026 ↗ |
| Fidelity Advisor Capital Development Fund Fidelity Destiny Portfolios | 39,500 | 11.9M $ | 0.19 % | 0.03 % | as of Jun 30, 2026 ↗ |
| Dimensional US High Profitability ETF Dimensional ETF Trust | 38,958 | 8M $ | 0.07 % | 0.03 % | as of Jul 31, 2026 ↗ |
| LVIP Global Equity Managed Volatility Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 38,799 | 11.7M $ | 1.21 % | 0.03 % | as of Jun 30, 2026 ↗ |
| Fidelity ZERO Large Cap Index Fund Fidelity Concord Street Trust | 38,149 | 7.8M $ | 0.04 % | 0.03 % | as of Jul 31, 2026 ↗ |
| LVIP American Century Capital Appreciation Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 37,569 | 11.3M $ | 2.39 % | 0.03 % | as of Jun 30, 2026 ↗ |
| Victory Pioneer Disciplined Growth Fund Victory Portfolios IV | 36,801 | 11.1M $ | 0.47 % | 0.03 % | as of May 31, 2026 ↗ |
| VY(R) T. ROWE PRICE DIVERSIFIED MID CAP GROWTH PORTFOLIO Voya Partners Inc | 35,921 | 10.8M $ | 1.12 % | 0.03 % | as of Jun 30, 2026 ↗ |
| Schwab Select Large Cap Growth Fund LAUDUS TRUST | 35,858 | 10.8M $ | 0.49 % | 0.03 % | as of Jun 30, 2026 ↗ |
| iShares Russell 3000 ETF iShares Trust | 35,757 | 10.8M $ | 0.06 % | 0.03 % | as of Jun 30, 2026 ↗ |
| LVIP American Century Ultra(R) Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 35,400 | 10.7M $ | 0.83 % | 0.03 % | as of Jun 30, 2026 ↗ |
| Fidelity Growth Strategies K6 Fund Fidelity Mt. Vernon Street Trust | 35,380 | 10.7M $ | 0.96 % | 0.03 % | as of May 31, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Equity Fund JNL Series Trust | 34,472 | 10.4M $ | 0.99 % | 0.03 % | as of Jun 30, 2026 ↗ |
| Nuveen ESG Mid-Cap Growth ETF NuShares ETF Trust | 34,383 | 7.1M $ | 2.02 % | 0.03 % | as of Jul 31, 2026 ↗ |
| WisdomTree U.S. Quality Growth Fund WisdomTree Trust | 32,387 | 9.7M $ | 0.37 % | 0.02 % | as of Jun 30, 2026 ↗ |
| Handelsbanken Global Index Criteria Handelsbanken Fonder AB | 32,085 | 101.1M SEK | 0.07 % | 0.02 % | as of Mar 31, 2026 ↗ |
| First Trust Long/Short Equity ETF First Trust Exchange-Traded Fund III | 31,339 | 6.4M $ | 0.26 % | 0.02 % | as of Jul 31, 2026 ↗ |
| Victory 500 Index Fund Victory Portfolios III | 31,164 | 6.4M $ | 0.04 % | 0.02 % | as of Jul 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 31,104 | 9.4M $ | 0.09 % | 0.02 % | as of May 31, 2026 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 3.16 % | as of Sep 30, 2025 ↗ |
| Fidelity Funds - Global Healthcare Fund FIL Investment Management (Luxembourg) S.A. | 1.61 % | as of Apr 30, 2025 ↗ |
| Pictet - Quest AI-Driven Global Equities Pictet Asset Management (Europe) S.A. | 0.36 % | as of Sep 30, 2025 ↗ |
| Amundi Dynamique Climat Amundi Asset Management | 0.03 % | as of Sep 30, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 3.99 % | as of Dec 31, 2025 ↗ |
| Corgi Genomics & Precision Medicine ETF Corgi ETF Trust I | 3.88 % | as of Jun 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 3.83 % | as of Jun 30, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 3.62 % | as of Jul 31, 2026 ↗ |
| Horizon Kinetics Medical ETF Listed Funds Trust | 3.42 % | as of Jun 30, 2026 ↗ |
| American Century Mid Cap Growth Impact ETF American Century ETF Trust | 3.19 % | as of May 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 3.19 % | as of May 31, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 3.17 % | as of Jul 31, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 3.16 % | as of Sep 30, 2025 ↗ |
| iShares Biotechnology ETF iShares Trust | 3.12 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 673 | -23 | 75,027,811 | -0.5 % |
| 2026Q2 | 696 | +10 | 75,428,168 | +1.0 % |
| 2026Q1 | 686 | +34 | 74,668,226 | +1.3 % |
| 2025Q4 | 652 | +34 | 73,684,788 | -2.6 % |
| 2025Q3 | 618 | -6 | 75,686,877 | +2.2 % |
| 2025Q2 | 624 | +46 | 74,063,375 | -0.1 % |
| 2025Q1 | 578 | -8 | 74,152,711 | -1.2 % |
| 2024Q4 | 586 | +51 | 75,034,343 | +9.1 % |
| 2024Q3 | 535 | +19 | 68,756,140 | +5.3 % |
| 2024Q2 | 516 | -5 | 65,297,179 | +1.9 % |
| 2024Q1 | 521 | -7 | 64,072,072 | -8.1 % |
| 2023Q4 | 528 | 69,739,098 |
Institutional managers
775 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 14,579,166 | 4.8B $ | as of Mar 31, 2026 |
| Capital World Investors | 10,802,348 | 3.6B $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 10,444,908 | 3.5B $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 9,471,181 | 3.1B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 6,323,752 | 2B $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 5,193,324 | 1.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 3,322,698 | 1.1B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,660,385 | 884.6M $ | as of Mar 31, 2026 |
| BAILLIE GIFFORD & CO | 2,493,866 | 825.1M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,992,577 | 659.3M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 1,935,925 | 640.5M $ | as of Mar 31, 2026 |
| Dodge & Cox | 1,929,253 | 638.3M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 1,802,363 | 596.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,432,748 | 474.1K $ | as of Mar 31, 2026 |
| Clearbridge Investments, LLC | 1,356,036 | 448.7M $ | as of Mar 31, 2026 |
| Orbis Allan Gray Ltd | 1,334,825 | 441.7M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 1,291,726 | 427.4M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 1,099,318 | 363.7M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 1,059,062 | 350.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,002,681 | 331.8M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 966,912 | 319.9M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 934,881 | 309.3M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 913,104 | 297.9M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 858,120 | 283.9M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 838,187 | 277.3M $ | as of Mar 31, 2026 |
Funds holding the debt of ALNYLAM PHARMACEUTICALS INC
39 funds declare 48 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of ALNYLAM PHARMACEUTICALS INC". https://titelia.com/en/stocks/alnylam-pharmaceuticals-inc-US02043Q1076